ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
120.434 IP-LS
Project title
Preclinical in vivo proof of mechanism study of selective mTORC1 inhibitors
Project status Finished
 
Start date 01.07.2022
End date 02.06.2025
 
Granted total costs 687'878.30  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % T410 Pharmaceuticals and related technologies
Last modification of the project